Belén López‐Millán

767 total citations
23 papers, 458 citations indexed

About

Belén López‐Millán is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Belén López‐Millán has authored 23 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Hematology. Recurrent topics in Belén López‐Millán's work include Acute Myeloid Leukemia Research (6 papers), Mesenchymal stem cell research (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Belén López‐Millán is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Mesenchymal stem cell research (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Belén López‐Millán collaborates with scholars based in Spain, France and United States. Belén López‐Millán's co-authors include Juan Iovanna, Pablo Menéndez, Rafael Díaz de la Guardia, Clara Bueno, Céline Loncle, Gwen Lomberk, Raúl Urrutia, María Inés Molejon, José Luís Fuster and Daniel Grasso and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Scientific Reports.

In The Last Decade

Belén López‐Millán

20 papers receiving 455 citations

Peers

Countries citing papers authored by Belén López‐Millán

Since Specialization

Citations

This map shows the geographic impact of Belén López‐Millán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belén López‐Millán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belén López‐Millán more than expected).

Fields of papers citing papers by Belén López‐Millán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belén López‐Millán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belén López‐Millán. The network helps show where Belén López‐Millán may publish in the future.

Co-authorship network of co-authors of Belén López‐Millán

This figure shows the co-authorship network connecting the top 25 collaborators of Belén López‐Millán. A scholar is included among the top collaborators of Belén López‐Millán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belén López‐Millán. Belén López‐Millán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of the extracellular protease ADAMTS1 reveals an antitumorigenic program involving the action of NIDOGEN-1 on macrophage polarization 2025 ·OncoImmunology ·(unknown), (unknown), (unknown), Juan Antonio Villatoro-García, Ana María García‐Muñoz, (unknown), María del Carmen Plaza‐Calonge, (unknown), Belén López‐Millán, Carmela Ricciardelli, Darryl L. Russell, Pedro Carmona‐Sáez, Juan Carlos Rodríguez‐Manzaneque	0
2	The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia 2022 ·Cancers ·Belén López‐Millán, Paula Costales, Francisco Gutiérrez‐Agüera, Rafael Díaz de la Guardia, Heleia Roca-Ho, Meritxell Vinyoles, (unknown), Rémi Safi, Julio Castaño, Paola Romecín, Manuel Ramı́rez, Eduardo Anguita, Irmela Jeremias, Lurdes Zamora, Juan Carlos Rodríguez‐Manzaneque, Clara Bueno, Francisco Morís, Pablo Menéndez	2
3	Robust In Vitro and In Vivo Immunosuppressive and Anti-inflammatory Properties of Inducible Caspase-9-mediated Apoptotic Mesenchymal Stromal/Stem Cell 2022 ·Stem Cells Translational Medicine ·Paola Romecín, Meritxell Vinyoles, Belén López‐Millán, Rafael Díaz de la Guardia, Noemí M. Atuchá, Sergi Querol, Clara Bueno, Raquel Benítez, Elena González‐Rey, Mario Delgado, Pablo Menéndez	9
4	Engraftment characterization of risk-stratified AML in NSGS mice 2021 ·Blood Advances ·Rafael Díaz de la Guardia, Talía Velasco-Hernández, Francisco Gutiérrez‐Agüera, Heleia Roca-Ho, Òscar Molina, César Nombela‐Arrieta, Álex Bataller, José Luís Fuster, Eduardo Anguita, Susana Vives, Lurdes Zamora, Josep Nomdedéu, María Teresa Gómez‐Casares, Manuel Ramı́rez, Hélène Lapillonne, Verónica Ramos–Mejía, Juan Carlos Rodríguez‐Manzaneque, Clara Bueno, Belén López‐Millán, Pablo Menéndez	9
5	Manifestaciones neurológicas del lupus eritematoso sistémico: Revisión de literatura. 2021 ·Revista Ecuatoriana de Neurologia ·Jorge Vásconez-González, Belén López‐Millán, (unknown), (unknown), Claudio Galarza-Maldonado, (unknown), Andrés López‐Cortés, Esteban Ortiz‐Prado	0
6	Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells 2020 ·Molecular Therapy — Nucleic Acids ·Paolo Petazzi, Raúl Torres, A Fidanza, Heleia Roca-Ho, Francisco Gutiérrez‐Agüera, Julio Castaño, Sandra Rodríguez, Rafael Díaz de la Guardia, Belén López‐Millán, Anna Bigas, Lesley M. Forrester, Clara Bueno, Pablo Menéndez	10
7	Bone Marrow Clonogenic Myeloid Progenitors from NPM1-Mutated AML Patients Do Not Harbor the NPM1 Mutation: Implication for the Cell-Of-Origin of NPM1+ AML 2020 ·Genes ·Rafael Díaz de la Guardia, Laura González-Silva, Belén López‐Millán, Juan José Rodríguez‐Sevilla, (unknown), Clara Bueno, Eduardo Anguita, Susana Vives, Laura Palomo, Hélène Lapillonne, Ignacio Varela, Pablo Menéndez	2
8	NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia 2019 ·Leukemia ·Belén López‐Millán, Diego Sánchez‐Martínez, Heleia Roca-Ho, Francisco Gutiérrez‐Agüera, Òscar Molina, Rafael Díaz de la Guardia, Raúl Torres, José Luís Fuster, Paola Ballerini, (unknown), César Nombela‐Arrieta, Clara Bueno, Pablo Menéndez	30
9	The chromatin nuclear protein NUPR1L is intrinsically disordered and binds to the same proteins as its paralogue 2018 ·Biochemical Journal ·José L. Neira, Belén López‐Millán, Paz Sevilla, Bruno Rizzuti, A. Cámara-Artigas, Miguel Vidal, Juan Iovanna	13
10	Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes 2017 ·Stem Cell Reports ·Rafael Díaz de la Guardia, Belén López‐Millán, Jessie R. Lavoie, Clara Bueno, Julio Castaño, María Teresa Gómez‐Casares, Susana Vives, Laura Palomo, Manel Juan, Julio Delgado, (unknown), Josep Nomdedéu, (unknown), José Luís Fuster, Eduardo Anguita, Michael Rosu‐Myles, Pablo Menéndez	75
11	Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease 2017 ·Experimental & Molecular Medicine ·Belén López‐Millán, Rafael Díaz de la Guardia, Heleia Roca-Ho, (unknown), Jessie R. Lavoie, Michael Rosu‐Myles, Elena González‐Rey, Francisco O′Valle, Gabriel Criado, Mario Delgado, Pablo Menéndez	19
12	Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase 2016 ·Arthritis Research & Therapy ·Elena Gonzalo-Gil, (unknown), María Galindo-Izquierdo, Rafael Díaz de la Guardia, Belén López‐Millán, Clara Bueno, Pablo Menéndez, José L. Pablos, Gabriel Criado	43
13	Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells 2016 ·Stem Cells ·(unknown), Eddy H.J. Van Roon, Damià Romero–Moya, Belén López‐Millán, Ronald W. Stam, Dolors Colomer, Mahito Nakanishi, Clara Bueno, Pablo Menéndez	12
14	IL17 Functions through the Novel REG3β–JAK2–STAT3 Inflammatory Pathway to Promote the Transition from Chronic Pancreatitis to Pancreatic Cancer 2015 ·Cancer Research ·Céline Loncle, Laia Bonjoch, Emma Folch‐Puy, Belén López‐Millán, Sophie Lac, María Inés Molejon, Eduardo Chuluyán, Pierre Cordelier, Pierre Dubus, Gwen Lomberk, Raúl Urrutia, Daniel Closa, Juan Iovanna	82
15	Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation 2015 ·Scientific Reports ·Daniel Grasso, (unknown), Gwen Lomberk, María Inés Molejon, Céline Loncle, María Noé Garcia, Belén López‐Millán, Raúl Urrutia, Juan Iovanna	24
16	Functional Characterization of Nupr1L, A Novel p53‐Regulated Isoform of the High‐Mobility Group (HMG)‐Related Protumoral Protein Nupr1 2015 ·Journal of Cellular Physiology ·Belén López‐Millán, María Noé Garcia, Daniel Grasso, (unknown), María Inés Molejon, Gabriel Velez, Gwen Lomberk, José L. Neira, Raúl Urrutia, Juan Iovanna	14
17	An Enriched, Cereal-Based Bread Affects Appetite Ratings and Glycemic, Insulinemic, and Gastrointestinal Hormone Responses in Healthy Adults in a Randomized, Controlled Trial, 2014 ·Journal of Nutrition ·(unknown), Belén López‐Millán, (unknown), Estefanía Sánchez-Rodríguez, María Dolores Ruiz‐López, Ángel Gil, María Dolores Mesa	21
18	IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation 2014 ·Journal of Clinical Investigation ·María Noé Garcia, Daniel Grasso, Belén López‐Millán, Tewfik Hamidi, Céline Loncle, Richard Tomasini, Gwen Lomberk, Françoise Porteu, Raúl Urrutia, Juan Iovanna	35
19	[Macronutrients, food intake and body weight; the role of fat]. 2014 ·PubMed ·(unknown), (unknown), (unknown), Belén López‐Millán, (unknown), (unknown)	8
20	Expression profile of telomere‐associated genes in multiple myeloma 2012 ·Journal of Cellular and Molecular Medicine ·Rafael Díaz de la Guardia, Purificación Catalina, (unknown), Carolina Elosua, (unknown), Belén López‐Millán, Verónica Ayllón, Gertrudis Ligero, Irma Slavutsky, Paola Leone	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact